Delivery Order SPE2DB22D3301-SPE2DB24FY7PP
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Veklury (100 mg vials) to the Defense Logistics Agency (DLA). The $13,618.40 firm fixed price delivery order contract has a completion date of July 1, 2024 and was awarded on June 7, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of...
- This federal contract award, valued at $1,584.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a period of performance through April 3, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VEKLURY 100 MG VIALS. The $13,606.80 firm fixed-price contract has an ultimate completion date of October 21, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a firm fixed-price delivery order valued at $6,809.20. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order valued at $2,042.76 for the delivery of VEKLURY 100 MG VIALS. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VEKLURY 100 MG VIALS. The award is a Firm Fixed Price Delivery Order with a ceiling value of $15,848.80 and a period of performance ending on July 1, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $15,848.80 and a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP5W0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,618.40 firm fixed-price delivery order is for the supply of VEKLURY 100 MG vials, a critical COVID-19 treatment medication. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the supply of VEKLURY 100 MG vials. The order has a ceiling value of $7,490.12 and a completion date of April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025. The...
- This federal contract award is a delivery order (SPE2DB23FP5M8) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm-fixed-price contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY7PPDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Veklury 100 mg vials. The fixed-price contract, valued at $7,490.12, was awarded on May 29, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/29/24 |